Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral prednisolone for acquired lumbar spinal canal stenosis
IRCT20180729040636N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of prednisolone in lumbar spinal stenosis (LSS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Ability to walk painlessly, Oswestry Disability Index and 1 more. Started Jan 2019; status: completed.
02
Drugs
prednisolone
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on IRCT20180729040636N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180729040636N1.